Tokyo Tape
Sign in
← Jmdc

Half-year report · HY

4483.TEDINET S100X27L
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥23.1bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥41.7bn2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥18.5bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥4.0bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥3.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥3.7bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥8.5bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.4bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.3bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.2bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.3bn2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥2.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥152.7bnat 2025-09-30Cons.Assets IFRS
Total assets¥143.0bnat 2025-03-31Cons.Assets IFRS
Total assets¥136.1bnat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥72.8bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥64.5bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥79.9bnat 2025-09-30Cons.Equity IFRS
Net assets / equity¥78.5bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥72.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥70.7bnat 2024-03-31vCons.Equity IFRS
Equity (owners)¥79.5bnat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥78.0bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥72.1bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥35.9bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥32.2bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥27.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.5bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥6.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥14.7bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥10.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥5.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥3.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥4.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥1.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥6.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥6.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥36.352025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥111.342024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥33.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥362025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥110.232024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥33.182024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio52.1%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.6%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.9%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥428m
Healthcare Big Datareportable segmentrevenue2025-04-01 → 2025-09-30¥19.9bn
Healthcare Big Datareportable segmentrevenue external2025-04-01 → 2025-09-30¥19.9bn
Healthcare Big Datareportable segmentsegment profit2025-04-01 → 2025-09-30¥4.8bn
Tele Medicinereportable segmentrevenue2025-04-01 → 2025-09-30¥3.2bn
Tele Medicinereportable segmentrevenue external2025-04-01 → 2025-09-30¥3.2bn
Tele Medicinereportable segmentsegment profit2025-04-01 → 2025-09-30¥1.2bn
—segment totalrevenue2025-04-01 → 2025-09-30¥23.1bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥23.1bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥6.0bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥21m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥21m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥401m
Healthcare Big Datareportable segmentrevenue2024-04-01 → 2024-09-30¥15.5bn
Healthcare Big Datareportable segmentrevenue external2024-04-01 → 2024-09-30¥15.5bn
Healthcare Big Datareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥21m
Healthcare Big Datareportable segmentsegment profit2024-04-01 → 2024-09-30¥3.8bn
Tele Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥3.1bn
Tele Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥3.1bn
Tele Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥18.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥18.5bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥21m
—segment totalsegment profit2024-04-01 → 2024-09-30¥4.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 759
ItemContextValueUnit
Revenue IFRSPrior1InterimDuration_jpcrp040300-ssr_E35308-000TeleMedicineReportableSegmentMember3058000000JPY
Revenue IFRSPrior1InterimDuration_ReportableSegmentsMember18570000000JPY
Revenue IFRSPrior1InterimDuration_ReconcilingItemsMember-21000000JPY
Revenue IFRSPrior1InterimDuration18548000000JPY
Segment profit loss IFRSPrior1InterimDuration_jpcrp040300-ssr_E35308-000HealthcareBigDataReportableSegmentMember3751000000JPY
Segment profit loss IFRSPrior1InterimDuration_jpcrp040300-ssr_E35308-000TeleMedicineReportableSegmentMember1130000000JPY
Segment profit loss IFRSPrior1InterimDuration_ReportableSegmentsMember4882000000JPY
Segment profit loss IFRSPrior1InterimDuration_ReconcilingItemsMember-401000000JPY
Segment profit loss IFRSPrior1InterimDuration4480000000JPY
Revenue from external customers IFRSInterimDuration_jpcrp040300-ssr_E35308-000HealthcareBigDataReportableSegmentMember19893000000JPY
Revenue from external customers IFRSInterimDuration_jpcrp040300-ssr_E35308-000TeleMedicineReportableSegmentMember3186000000JPY
Revenue from external customers IFRSInterimDuration_ReportableSegmentsMember23080000000JPY
Revenue from external customers IFRSInterimDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSInterimDuration23080000000JPY
Intersegment revenue IFRSInterimDuration_jpcrp040300-ssr_E35308-000HealthcareBigDataReportableSegmentMember－JPY
Intersegment revenue IFRSInterimDuration_jpcrp040300-ssr_E35308-000TeleMedicineReportableSegmentMember－JPY
Intersegment revenue IFRSInterimDuration_ReportableSegmentsMember－JPY
Intersegment revenue IFRSInterimDuration_ReconcilingItemsMember－JPY
Intersegment revenue IFRSInterimDuration－JPY
Revenue IFRSInterimDuration_jpcrp040300-ssr_E35308-000HealthcareBigDataReportableSegmentMember19893000000JPY
Revenue IFRSInterimDuration_jpcrp040300-ssr_E35308-000TeleMedicineReportableSegmentMember3186000000JPY
Revenue IFRSInterimDuration_ReportableSegmentsMember23080000000JPY
Revenue IFRSInterimDuration_ReconcilingItemsMember－JPY
Revenue IFRSInterimDuration23080000000JPY
Segment profit loss IFRSInterimDuration_jpcrp040300-ssr_E35308-000HealthcareBigDataReportableSegmentMember4800000000JPY
Segment profit loss IFRSInterimDuration_jpcrp040300-ssr_E35308-000TeleMedicineReportableSegmentMember1152000000JPY
Segment profit loss IFRSInterimDuration_ReportableSegmentsMember5952000000JPY
Segment profit loss IFRSInterimDuration_ReconcilingItemsMember-428000000JPY
Segment profit loss IFRSInterimDuration5524000000JPY
Segment profit loss IFRSPrior1InterimDuration4480000000JPY
Segment profit loss IFRSInterimDuration5524000000JPY
Depreciation and amortization operating expenses IFRSPrior1InterimDuration1285000000JPY
Depreciation and amortization operating expenses IFRSInterimDuration1510000000JPY
Other income IFRSPrior1InterimDuration61000000JPY
Other income IFRSInterimDuration51000000JPY
Other expenses IFRSPrior1InterimDuration103000000JPY
Other expenses IFRSInterimDuration39000000JPY
Operating profit loss IFRSPrior1InterimDuration3153000000JPY
Operating profit loss IFRSInterimDuration4025000000JPY
Finance income IFRSPrior1InterimDuration3000000JPY
Finance income IFRSInterimDuration36000000JPY
Finance costs IFRSPrior1InterimDuration86000000JPY
Finance costs IFRSInterimDuration405000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1InterimDuration0JPY
Share of profit loss of investments accounted for using equity method IFRSInterimDuration0JPY
Profit loss before tax IFRSPrior1InterimDuration3071000000JPY
Profit loss before tax IFRSInterimDuration3657000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass